Clinical Trial Update: Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus Nephritis [Phase 3]

View source ↗

Summary

Phase 3 trial investigating belimumab with multi-target induction therapy for lupus nephritis; current status is unknown with remission as a condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: Nanjing University School of Medicine | Conditions: Lupus Nephritis, Remission | Phase 3 | Status: UNKNOWN